Welcome to our dedicated page for XWELL SEC filings (Ticker: XWEL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Wondering where XWELL’s next growth airport will be or how COVID-19 testing revenue is trending? Most investors start by hunting through the company’s SEC disclosures—but XWELL’s filings can span hundreds of pages of lease details, passenger-traffic assumptions, and spa build-out costs. This page streamlines that search, placing every document in one spot and explaining each with plain-language AI summaries.
Start with the XWELL annual report 10-K simplified section to see segment revenue for XpresSpa, Treat, and XpresTest, plus granular risk factors tied to travel demand. Need quicker updates? Our real-time feed flags every XWELL quarterly earnings report 10-Q filing the moment it hits EDGAR, then highlights foot-traffic metrics and cash-flow changes in a concise dashboard.
If you’re tracking leadership confidence, the XWELL insider trading Form 4 transactions tab shows share purchases or sales minutes after they’re filed. Prefer a single stream? The platform groups all XWELL Form 4 insider transactions real-time with executive titles so you can spot patterns before the next earnings call.
- XWELL proxy statement executive compensation reveals how bonuses link to spa EBITDA.
- XWELL 8-K material events explained breaks down new airport contracts or lease renegotiations in plain English.
- Interactive charts deliver instant XWELL earnings report filing analysis without manually poring over PDFs.
Powered by Stock Titan’s AI, every paragraph comes with a one-click “Explain” tool—perfect for understanding XWELL SEC documents with AI. From dividend policy shifts to XWELL executive stock transactions Form 4, we surface what matters so you can make timely, informed decisions.
XWELL SEC filings explained simply—no more sifting, just answers.
Color Star Technology Co., Ltd. (NASDAQ: ADD) reported the results of its 29 June 2025 Annual General Meeting in a Form 6-K filing. Holders of 17,083,723 ordinary shares, representing 57.9 % of outstanding shares, formed a quorum and approved every agenda item.
Key resolutions:
- Reverse Share Split & Share Consolidation: Board may implement a reverse split at a ratio between 1-for-5 and 1-for-100. This reduces the share count and raises the par value while keeping authorised capital at US$32 million. Vote: 99.0 % in favour (16.92 m For / 0.16 m Against).
- Corporate Rebrand: Company name will change to Zeta Network Group. Vote: 99.3 % in favour (16.97 m For).
- Articles Amendment: Adoption of a Seventh Amended & Restated Memorandum and Articles to reflect the share consolidation and name change (99.3 % support).
- 2025 Equity Incentive Plan: Authorises new share-based awards; passed with 99.1 % support.
- Board Elections: Five directors (Wei Zhang, Hung-Jen Kuo, Honglei Jiang, Yan Zhang, Samantha Huang) re-elected with ~99.2 % approval each.
- Auditor Ratification: Assentsure PAC retained for FY 2025 (99.5 % approval).
- Routine filings and adjournment authorities also approved.
Implications for investors: The reverse split authority provides flexibility to lift a depressed share price or meet exchange listing requirements, but may compress existing shareholdings depending on the final ratio chosen. The equity plan could introduce dilution over time, while the rebrand signals a strategic repositioning. No financial performance metrics were disclosed in this filing.
XWELL, Inc. (Nasdaq: XWEL) has filed Amendment No. 3 to its Form S-3 shelf, registering 30,440,060 common shares for resale by prior investors.
The shares relate to a January 14 2025 private placement comprising: (i) 4,000 Series G convertible preferred shares translating into 23,952,096 conversion shares at a floor price of $0.167; (ii) 5,347,594 shares underlying cash-exercise warrants (Series A at $1.496, Series B at $1.7952); and (iii) up to 1,140,370 dividend shares accruing at 8 % per annum, compounded quarterly, through July 2030.
The registered amount equals roughly 557 % of the company’s outstanding common stock as of June 18 2025, signalling the potential for substantial dilution if all securities are issued. Proceeds from any resale go to the selling stockholders; XWELL would receive funds only if warrants are exercised for cash, earmarked for general corporate purposes. No underwriter is engaged, and sales may occur on Nasdaq or in private transactions.
XWELL is a non-accelerated, smaller-reporting company. Its shares last traded at $0.9039 on June 18 2025.
FAQ
What is the current stock price of XWELL (XWEL)?
What is the market cap of XWELL (XWEL)?
What is the core business of XWELL Inc.?
How does XWELL generate its revenue?
What are the primary brands under XWELL Inc.?
How does the company integrate biosecurity into its offerings?
What differentiates XpresSpa® from other travel wellness providers?
How does XWELL maintain high service quality across its brands?
